{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:40:33Z","timestamp":1722890433811},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.mehy.2004.07.024","type":"journal-article","created":{"date-parts":[[2004,9,28]],"date-time":"2004-09-28T18:37:14Z","timestamp":1096396634000},"page":"487-494","source":"Crossref","is-referenced-by-count":10,"title":["A possible link between multiple sclerosis and Creutzfeldt\u2013Jakob disease based on clinical, genetic, pathological and immunological evidence involving Acinetobacter bacteria"],"prefix":"10.1016","volume":"64","author":[{"given":"Alan","family":"Ebringer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clyde","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Boden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2004.07.024_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1172\/JCI21357","article-title":"Multiple sclerosis","volume":"113","author":"Hafler","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2004.07.024_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000059518","article-title":"Distribution of multiple sclerosis in Sweden based on mortality and disability compensation statistics","volume":"21","author":"Landtblom","year":"2002","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.mehy.2004.07.024_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000067111","article-title":"Geographical and temporal distribution of mortality rates for multiple sclerosis in Canada, 1965\u20131994","volume":"22","author":"Warren","year":"2003","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.mehy.2004.07.024_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/scnp.2003.50001","article-title":"The classic and variant forms of Creutzfeldt\u2013Jakob disease","volume":"8","author":"Irani","year":"2003","journal-title":"Semin Clin Neuropsychiatry"},{"key":"10.1016\/j.mehy.2004.07.024_bib5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ana.410430611","article-title":"Descriptive epidemiology of Creutzfeldt\u2013Jakob disease in six European countries 1993\u20131995","volume":"43","author":"Will","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2004.07.024_bib6","first-page":"121","article-title":"Clinical features of variant Creutzfeldt\u2013Jakob disease","volume":"284","author":"Will","year":"2004","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.mehy.2004.07.024_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1600-0463.2002.100102.x","article-title":"Prion diseases. An overview","volume":"110","author":"Dalsgaard","year":"2002","journal-title":"APMIS"},{"key":"10.1016\/j.mehy.2004.07.024_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/367781","article-title":"HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course","volume":"72","author":"Barcellos","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.mehy.2004.07.024_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(03)12455-5","article-title":"MHC typing in variant Creutzfeldt\u2013Jakob disease","volume":"361","author":"Pepys","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.07.024_bib10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/brain\/122.10.1823","article-title":"Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene","volume":"122","author":"Mallucci","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.mehy.2004.07.024_bib11","first-page":"27","article-title":"Report on the first polish case of the Gerstmann\u2013Straussler\u2013Scheinker syndrome","volume":"39","author":"Kulczycki","year":"2001","journal-title":"Folia Neuropathol"},{"key":"10.1016\/j.mehy.2004.07.024_bib12","first-page":"153","article-title":"Clinical and differential diagnosis of Creutzfeldt\u2013Jakob disease","volume":"16","author":"Poser","year":"2000","journal-title":"Arch Virol Suppl"},{"key":"10.1016\/j.mehy.2004.07.024_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1034\/j.1600-0463.2002.100111.x","article-title":"Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests","volume":"110","author":"Zerr","year":"2002","journal-title":"APMIS"},{"key":"10.1016\/j.mehy.2004.07.024_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/070674370404900302","article-title":"The neuropsychiatry of multiple sclerosis","volume":"49","author":"Feinstein","year":"2004","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.mehy.2004.07.024_bib15","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/archneur.58.10.1602","article-title":"Cognitive dysfunction in early-onset multiple sclerosis. A reappraisal after 10 years","volume":"58","author":"Amato","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mehy.2004.07.024_bib16","series-title":"McAlpine\u2019s multiple sclerosis","first-page":"145","article-title":"Symptoms and signs of multiple sclerosis","author":"Matthews","year":"1998"},{"key":"10.1016\/j.mehy.2004.07.024_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.10317","article-title":"Parkinsonism as a manifestation of multiple sclerosis","volume":"18","author":"Folgar","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.mehy.2004.07.024_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1440-1789.2001.00407.x","article-title":"An atypical case of sporadic Creutzfeldt\u2013Jakob disease with Parkinson\u2019s disease","volume":"21","author":"Iida","year":"2001","journal-title":"Neuropathology"},{"key":"10.1016\/j.mehy.2004.07.024_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion","volume":"55","author":"Barnnett","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mehy.2004.07.024_bib20","series-title":"Greenfield\u2019s neuropathology","first-page":"471","article-title":"Demyelinating diseases","author":"Prineas","year":"2002"},{"key":"10.1016\/j.mehy.2004.07.024_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0928-4680(01)00072-4","article-title":"Quantification of the pathological changes with laminar depth in the cortex in sporadic Creutzfeldt\u2013Jakob disease","volume":"8","author":"Armstrong","year":"2001","journal-title":"Pathophysiology"},{"key":"10.1016\/j.mehy.2004.07.024_bib22","first-page":"163","article-title":"Myelinated axon undergoes complete demyelination in the panencephalopathic \u2013 but it is merely subjected to the Wallerian degeneration in the polioencephalopathic type of transmissible spongiform encephalopathies","volume":"48","author":"Liberski","year":"1997","journal-title":"Pol J Pathol"},{"key":"10.1016\/j.mehy.2004.07.024_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0022-510X(84)90196-5","article-title":"On the white matter lesions of the Creutzfeldt\u2013Jakob disease: can a new sub entity be recognized in man?","volume":"63","author":"Macchi","year":"1984","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mehy.2004.07.024_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-510X(87)90008-6","article-title":"Spongiform encephalopathy with extensive involvement of white matter","volume":"82","author":"Cruz-Sanchez","year":"1987","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mehy.2004.07.024_bib25","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/jnnp.2003.021915","article-title":"Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis","volume":"75","author":"Davies","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mehy.2004.07.024_bib26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00143137","article-title":"Mechanism of the damage to myelinated axons in experimental Creutzfeldt\u2013Jakob disease in mice: an ultra structural study","volume":"7","author":"Liberski","year":"1991","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.mehy.2004.07.024_bib27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Medical progress: multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2004.07.024_bib28","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1046\/j.1537-2995.2001.41121509.x","article-title":"C-reactive protein and IL-6: new marker proteins for the diagnosis of CJD in plasma?","volume":"41","author":"Volkel","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.mehy.2004.07.024_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2003.09.010","article-title":"Complement activation in human prion disease","volume":"15","author":"Kovacs","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.mehy.2004.07.024_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0197-4580(01)00236-6","article-title":"The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt\u2013Jakob disease","volume":"23","author":"Van Everbroeck","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2004.07.024_bib31","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/JVI.77.6.3799-3808.2003","article-title":"T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies","volume":"77","author":"Lewicki","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2004.07.024_bib32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s004150200026","article-title":"Oligoclonal bands and antibody responses in multiple sclerosis","volume":"249","author":"Correale","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.mehy.2004.07.024_bib33","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(77)92473-4","article-title":"Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in Cryptococcal meningitis","volume":"1","author":"Porter","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.07.024_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000114916","article-title":"Mumps meningitis: prolonged pleocytosis and occurrence of mumps virus-specific oligoclonal IgG in the cerebrospinal fluid","volume":"17","author":"Vandvik","year":"1978","journal-title":"Eur Neurol"},{"key":"10.1016\/j.mehy.2004.07.024_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.410110107","article-title":"Neurosyphilis: intrathecal synthesis of oligoclonal antibodies to Treponema pallidum","volume":"11","author":"Vartdal","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2004.07.024_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1056\/NEJM198607313150502","article-title":"Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease","volume":"315","author":"Harrington","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2004.07.024_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2990.2002.t01-2-00427.x","article-title":"Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheirmer\u2019s disease and Creutzfeldt\u2013Jakob disease","volume":"28","author":"Green","year":"2002","journal-title":"Neuropath Appl Neurobiol"},{"key":"10.1016\/j.mehy.2004.07.024_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-510X(03)00083-2","article-title":"Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis","volume":"212","author":"Satoh","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mehy.2004.07.024_bib39","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00415-004-0336-0","article-title":"Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG","volume":"251","author":"Bartosik-Psujek","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.mehy.2004.07.024_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-510X(02)00349-0","article-title":"Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis","volume":"206","author":"Dharmasaroja","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mehy.2004.07.024_bib41","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1212\/WNL.58.9.1372","article-title":"Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit","volume":"58","author":"Silber","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2004.07.024_bib42","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1073\/pnas.82.10.3485","article-title":"The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt\u2013Jakob disease, and other neurologic diseases","volume":"82","author":"Toh","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2004.07.024_bib43","first-page":"371","article-title":"Antibodies to axonal neurofilaments in Creutzfeldt\u2013Jakob disease and other organic dementias","volume":"33","author":"Mitrova","year":"1989","journal-title":"Acta Virol"},{"key":"10.1016\/j.mehy.2004.07.024_bib44","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1212\/WNL.29.12.1610","article-title":"Cerebrospinal fluid and serum immunoglobulins and C3 in Creutzfeldt\u2013Jakob disease","volume":"29","author":"Galvez","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2004.07.024_bib45","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/CDLI.8.6.1181-1188.2001","article-title":"Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin\u2013Acinetobacter\u2013neurofilament antibody index","volume":"8","author":"Hughes","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.mehy.2004.07.024_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-5728(03)00274-1","article-title":"Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis","volume":"144","author":"Hughes","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2004.07.024_bib47","unstructured":"Allerberger F, Rashid T, Hughes L, Wilson C, Ebringer A. Anti-Acinetobacter and anti-neuronal antibodies in Austrian patients with multiple sclerosis and other neurological diseases. J Neurol [submitted]"},{"key":"10.1016\/j.mehy.2004.07.024_bib48","unstructured":"Ebringer A, Rashid T, Wilson C, et al. Multiple sclerosis, sporadic Creutzfeldt\u2013Jakob disease and BSE: are they autoimmune diseases evoked by Acinetobacter microbes showing molecular mimicry to brain antigens. J Autoimmun in press"},{"key":"10.1016\/j.mehy.2004.07.024_bib49","unstructured":"www.cjd.ed.ac.uk. UK Creutzfeldt\u2013Jakob Disease Surveillance Unit, Edinburgh. Eighth Annual Report; 1999"},{"key":"10.1016\/j.mehy.2004.07.024_bib50","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bmj.323.7317.858","article-title":"New variant Creutzfeldt\u2013Jakob disease: the epidemic that never was","volume":"323","author":"Venters","year":"2001","journal-title":"Br Med J"},{"key":"10.1016\/j.mehy.2004.07.024_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(98)08062-3","article-title":"Geographical distribution of variant CJD in the UK (excluding Northern Ireland)","volume":"353","author":"Cousens","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.07.024_bib52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/382779a0","article-title":"Transmission dynamics and epidemiology of BSE in British cattle","volume":"382","author":"Anderson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2004.07.024_bib53","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/jnnp.53.10.903","article-title":"Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?","volume":"53","author":"Miller","year":"1990","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mehy.2004.07.024_bib54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0300-483X(02)00249-4","article-title":"Fundamentals of prion biology and diseases","volume":"181","author":"DeArmond","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.mehy.2004.07.024_bib55","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1289\/ehp.971051172","article-title":"Bovine spongiform encephalopathy: is it an autoimmune disease due to bacteria showing molecular mimicry with brain antigens?","volume":"105","author":"Ebringer","year":"1997","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.mehy.2004.07.024_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2003.09.009","article-title":"Antibodies to prion and Acinetobacter peptide sequences in bovine spongiform encephalopathy","volume":"98","author":"Wilson","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.mehy.2004.07.024_bib57","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1084\/jem.144.4.1094","article-title":"Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever","volume":"144","author":"Husby","year":"1976","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2004.07.024_bib58","first-page":"972","article-title":"Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis","volume":"30","author":"Wilson","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2004.07.024_bib59","first-page":"472","article-title":"An ultra study of experimental demyelination and remyelination. III. Chronic experimental allergic encephalomyelitis in the central nervous system","volume":"21","author":"Prineas","year":"1969","journal-title":"Lab Invest"},{"key":"10.1016\/j.mehy.2004.07.024_bib60","first-page":"369","article-title":"Chronic experimental allergic encephalomyelitis in inbred guinea pigs. An ultrastructural study","volume":"31","author":"Raine","year":"1974","journal-title":"Lab Invest"},{"key":"10.1016\/j.mehy.2004.07.024_bib61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.6997994","article-title":"Autoantibodies against axonal neurofilaments in patients with kuru and Creutzfeldt\u2013Jakob disease","volume":"210","author":"Sotello","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.mehy.2004.07.024_bib62","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1128\/IAI.67.12.6591-6595.1999","article-title":"Autoantibodies to brain components and antibodies to Acinetobacter calcoaceticus are present in bovine spongiform encephalopathy","volume":"67","author":"Tiwana","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2004.07.024_bib63","first-page":"23","article-title":"Antibodies to Acinetobacter bacteria and bovine brain peptides, measured in bovine spongiform encephalopathy (BSE) in an attempt to develop an ante-mortem test","volume":"52","author":"Wilson","year":"2003","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/j.mehy.2004.07.024_bib64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/13590849409034540","article-title":"Are organophosphate pesticides involved in the causation of bovine spongiform encephalopathy (BSE)? Hypothesis based upon literature review and limited trials on BSE cattle","volume":"4","author":"Purdey","year":"1994","journal-title":"J Nutr Med"},{"key":"10.1016\/j.mehy.2004.07.024_bib65","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/brain\/118.6.1583","article-title":"Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss","volume":"118","author":"Davie","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.mehy.2004.07.024_bib66","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2249.2003.02053.x","article-title":"Monocyte-derived cytokines in multiple sclerosis","volume":"131","author":"Filion","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.mehy.2004.07.024_bib67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0165-5728(02)00464-2","article-title":"Nitric oxide metabolic determinations reveal continuous inflammation in multiple sclerosis","volume":"136","author":"Danilov","year":"2003","journal-title":"J Neuroimmunol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698770400458X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698770400458X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:52:41Z","timestamp":1624668761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698770400458X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S030698770400458X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2004.07.024","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}